Artemisinin resistance: The more we know, the more complicated it appears

Journal of Infectious Diseases

Volumn 211, Issue 5, 2015, Pages 667-669

  Sibley, Carol Hopkins ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antimalarial resistance; Artemisinin resistance; Malaria; Parasite clearance; Plasmodium falciparum

Indexed keywords

ARTEMISININ; CHLOROQUINE; PYRIMETHAMINE PLUS SULFADOXINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

AFRICA; ANTIMALARIAL DRUG RESISTANCE; CAMBODIA; DNA SEQUENCE; EDITORIAL; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GEOGRAPHICAL VARIATION (SPECIES); K13 GENE; NONHUMAN; PARASITE CLEARANCE; PARASITE ISOLATION; PARASITE LOAD; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTHEAST ASIA; STRAIN IDENTIFICATION; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; HUMAN; MALARIA FALCIPARUM; MALE; MUTATION; PARASITOLOGY; PREGNANCY;

ANTIMALARIALS; ARTEMISININS; DRUG RESISTANCE; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MUTATION; PLASMODIUM FALCIPARUM; PREGNANCY;

EID: 84942316168     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu469     Document Type: Editorial

References (25)

1. Peterson DS, Di Santi SM, Povoa M, Calvosa VS, Do Rosario VE, Wellems TE. Prevalence of the dihydrofolate reductase Asn-108 mutation as the basis for pyrimethamine-resistant falciparum malaria in the Brazilian Amazon. Am J Trop Med Hyg 1991;45:492-7.
2. Djimde A, Doumbo OK, Cortese JF, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 2001;344:257-63.
3. Kublin J, Dzinjalamala F, Kamwendo D, et al. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis 2002;185:380-8.
4. Plowe CV. Monitoring antimalarial drug resistance: making the most of the tools at hand. J Exp Biol 2003;206:3745-52.
5. Sibley CH, Price RN. Monitoring antimalar-ial drug resistance: Applying lessons learned from the past in a fast-moving present. Int J Parasitol: Drugs and Drug Resist 2012;2:126-33.
6. Noranate N, Durand R, Tall A, et al. Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled an-timalarial use. PLoS One 2007;2:e139.
7. Certain LK, Briceno M, Kiara SM, Nzila AM, Watkins WM, Sibley CH. Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987-2006. J Infect Dis 2008;197:1743-51.
8. Roper C, Pearce R, Bredenkamp B, et al. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet 2003;361:1174-81.
9. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T. Intercontinental spread of pyri-methamine-resistant malaria. Science 2004;305:1124.
10. Ariey F, Fandeur T, Durand R, et al. Invasion of Africa by a single pfcrt allele of South East Asian type. Malar J 2006;5:34.
11. WHO. Guidelines for the treatment of malaria. Geneva: World Health Organization, 2006.
12. White NJ. Delaying antimalarial drug resistance with combination chemotherapy. Para-ssitologia 1999;41:301-8.
13. Dondorp AM, Nosten F, Yi P, et al. Artemi-sinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009;361:455-67.
14. Flegg J, Guerin P, White N, Stepniewska K. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J 2011;10:339.
15. Phyo AP, Nkhoma S, Stepniewska K, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 2012;379:1960-6.
16. Kyaw MP, Nyunt MH, Chit K, et al. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. PLoS One 2013;8:e57689.
17. WHO. Global plan for containment of artemisinin resistance. http://www.who.int/malaria/publications/atoz/9789241500838/en/index.html. Accessed 10 August 2014.
18. Ariey F, Witkowski B, Amaratunga C, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 2014;505:50-5.
19. Takala-Harrison S, Jacob CG, Arze C, et al. Independent emergence of artemisinin resistance mutations among Plasmodium falcipa-rum in Southeast Asia. J Infect Dis 2015;211:670-9.
20. Taylor SM, Parobek CM, De Conti DK, et al. Absence of putative artemisinin resistance mutations among Plasmodium falciparum in sub-Saharan Africa: a molecular epi-demiologic study. J Infect Dis 2015;211:680-8.
21. Takala-Harrison S, Clark TG, Jacob CG, et al. Genetic loci associated with delayed clearance of Plasmodium falciparum following ar-temisinin treatment in Southeast Asia. Proc Natl Acad Sci USA 2013;110:240-5.
22. Ashley EA, Dhorda M, Fairhurst RM, et al. Spread of artemisinin resistance in Plasmodi-um falciparum malaria. N Engl J Med 2014;371:411-23.
23. Taylor SM, Parobek CM, Aragam N, et al. Pooled deep sequencing of Plasmodium falciparum isolates: an efficient and scalable tool to quantify prevailing malaria drug-resistance genotypes. J Infect Dis 2013;208:1998-2006.
24. Witkowski B, Amaratunga C, Khim N, et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect Dis 2013;13:1043-9.
25. Roper C, Alifrangis M, Ariey F, et al. Molecular surveillance for artemisinin resistance in Africa. Lancet Infect Dis 2014;14:668-70.